Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia.
暂无分享,去创建一个
Rohan Jayasuriya | Lisa Maher | Bin Jalaludin | J. Kaldor | R. Jayasuriya | B. Jalaludin | K. Chant | L. Maher | John M Kaldor | Kerry G Chant | Tim Sladden | Penny L Sargent | T. Sladden | Penny Sargent
[1] P. Bourgois,et al. The Everyday Violence of Hepatitis C Among Young Women Who Inject Drugs in San Francisco. , 2004, Human organization.
[2] J. Pawlotsky. Use and interpretation of virological tests for hepatitis C , 2002, Hepatology.
[3] D. Vlahov,et al. Socially desirable responding and self-reported HIV infection risk behaviors among intravenous drug users. , 1993, Addiction.
[4] D. Vlahov,et al. Prevalence and incidence of hepatitis C virus infection among young adult injection drug users. , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[5] M. MacDonald,et al. Risk factors for hepatitis C virus infection among injecting drug users in Sydney. , 1994, Genitourinary medicine.
[6] J. Kaldor,et al. Hepatitis C virus antibody prevalence among injecting drug users at selected needle and syringe programs in Australia, 1995–1997 , 2000 .
[7] P. Griffiths,et al. Evaluation of a Brief Intervention to Prevent Initiation into Injecting , 1998 .
[8] L. Maher,et al. Risk behaviours of young Indo‐Chinese injecting drug users in Sydney and Melbourne , 2001, Australian and New Zealand journal of public health.
[9] P. Bourgois,et al. The moral economies of homeless heroin addicts: confronting ethnography, HIV risk, and everyday violence in San Francisco shooting encampments. , 1998, Substance use & misuse.
[10] M. Busch,et al. Hepatitis C virus seroconversion among young injection drug users: relationships and risks. , 2002, The Journal of infectious diseases.
[11] D. Harte,et al. Cumulative incidence of hepatitis C seroconversion in a cohort of seronegative injecting drug users. , 2000, The New Zealand medical journal.
[12] B. Jalaludin,et al. Risk behaviors and antibody hepatitis B and C prevalence among injecting drug users in south‐western Sydney, Australia , 2004, Journal of gastroenterology and hepatology.
[13] J. Parry,et al. Incidence of hepatitis C virus and HIV among new injecting drug users in London: prospective cohort study , 2004, BMJ : British Medical Journal.
[14] J. Goudsmit,et al. Prevalence, incidence, and risk factors of hepatitis C virus infection among drug users in Amsterdam. , 1990, The Journal of infectious diseases.
[15] M. Schechter,et al. Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic , 2003, AIDS.
[16] D. D. Des Jarlais,et al. Hepatitis C Virus Infection Among Injection Drug Users: Survival Analysis of Time to Seroconversion , 2004, Epidemiology.
[17] L. Maher. Sexed Work: Gender, Race, and Resistance in a Brooklyn Drug Market , 1997 .
[18] J. Kaldor,et al. Epidemiology of hepatitis C virus infection in Australia. , 2003, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[19] J. de Irala,et al. Reliability of self-reported human immunodeficiency virus risk behaviors in a residential drug treatment population. , 1996, American journal of epidemiology.
[20] R. Garfein,et al. Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. , 2002, American journal of epidemiology.
[21] L. Maher. Don't leave us this way: ethnography and injecting drug use in the age of AIDS , 2002 .
[22] D. Vlahov,et al. Rapid transmission of hepatitis C virus among young injecting heroin users in Southern China. , 2004, International journal of epidemiology.
[23] M. Alter,et al. Epidemiology of Hepatitis C: Geographic Differences and Temporal Trends , 2000, Seminars in liver disease.
[24] C. Aitken,et al. Incidence of bloodborne virus infection and risk behaviours in a cohort of injecting drug users in Victoria, 1990‐1995 , 1997, The Medical journal of Australia.
[25] D. Vlahov,et al. Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland , 1997, Journal of clinical microbiology.
[26] M. Schechter,et al. Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection , 2022 .
[27] M. Hickman,et al. Measuring injecting risk behaviour in the second decade of harm reduction: a survey of injecting drug users in England. , 2000, Addiction.
[28] M. Alter,et al. Prevention of spread of hepatitis C , 2002, Hepatology.
[29] Nick Crofts,et al. Hepatitis C virus infection among a cohort of Victorian injecting drug users , 1993, The Medical journal of Australia.
[30] M. MacDonald,et al. Transmission of hepatitis C virus: rates, routes, and cofactors. , 1996, Epidemiologic reviews.
[31] J. Montaner,et al. Opportunities for prevention: Hepatitis C prevalence and incidence in a cohort of young injection drug users , 2002, Hepatology.
[32] D. Vlahov,et al. The natural history of hepatitis C virus infection: host, viral, and environmental factors. , 2000, JAMA.
[33] J. Duchin,et al. Sharing of drug preparation equipment as a risk factor for hepatitis C. , 2001, American journal of public health.
[34] A. Widell,et al. Continued transmission of hepatitis B and C viruses, but no transmission of human immunodeficiency virus among intravenous drug users participating in a syringe/needle exchange program. , 2000, Scandinavian journal of infectious diseases.